Skip to main content
. 2018 Nov 20;131(22):2683–2692. doi: 10.4103/0366-6999.245157

Figure 2.

Figure 2

LS mean change from baseline in DAS28-4 (ESR) through: (a) Month 6 in ORAL Sync (FAS, longitudinal model); (b) Month 12 in ORAL Sync by treatment sequence (FAS, longitudinal model); and (c) Month 48 in ORAL Sequel (FAS, no imputation). *P < 0.05; P < 0.001; P < 0.0001. BID: Twice daily; DAS28-4 (ESR): Disease Activity Score in 28 joints using erythrocyte sedimentation rate; FAS: Full analysis set; LS: Least squares; SE: Standard error.